Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Net Buyback Yield

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Percent.

The item "Net-Buyback-Yield" stands at 1.62 percent as of 09/30/2025.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Net Buyback Yield" stands at 1.62 Percent. This represents a decrease of -0.03 percentage points compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.59 percentage points compared to the value the year prior.
The 1 year change in percentage points is 1.59.
The 3 year change in percentage points is -0.5039.

The Serie's long term average value is 1.09 percent. It's latest available value, on 09/30/2025, is 0.525 percentage points higher, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 09/30/2024, to it's latest available value, on 09/30/2025, is +1.59.
The Serie's change in percentage points from it's maximum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is -0.577.

Net Buyback Yield for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Net Buyback Yield905,699,262,464.00
LogoJohnson & Johnson - Net Buyback Yield486,508,953,600.00
LogoAbbVie Inc - Net Buyback Yield399,570,305,024.00
LogoRoche Holding AG - Net Buyback Yield317,433,206,677.55
LogoAstraZeneca PLC - Net Buyback Yield280,205,508,085.11